Dual-action virolytic entry inhibitors against HIV-1
Dual-action virolytic entry inhibitors against HIV-1
批准号:
9268785
负责人:
CAMERON F ABRAMS
金额:
$46.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-20 至 2019-04-30
关键词:
AffinityBindingBinding SitesCellsComplexCyanovirin-NCytolysisDengueEbola virusEngineeringGoalsHIVHIV Envelope Protein gp120HIV-1IndividualInfectionInfluenzaInterruptionLeadLectinLyticMembraneMolecularMolecular ConformationMutagenesisMutationPhenotypePolysaccharidesPropertyProteinsReportingRoleSamplingScienceStructural ModelsStructureSurfaceUnited States National Institutes of HealthVariantVirionVirusVisionWorkchemical synthesisclinically relevantcombatcombinatorialdesignenv Gene Productsinhibitor/antagonistinnovationnovelparticlepreventprogramspublic health relevancesimulationsmall molecule inhibitorstoichiometrytransmission processvirus envelope
中文摘要
描述(由申请人提供):该项目的总体目标是开发一种新的针对HIV-1包膜的范例,以便在此之前特异性地灭活病毒
宿主细胞相遇。独一无二的HIV-1特异性包膜刺突蛋白,由嵌入在病毒膜上的gp120和gp41杂二聚体三聚体组成,是唯一暴露在病毒粒子外部的病毒特异性蛋白,因此是一个有吸引力的中和病毒的靶标。通过靶向env蛋白来灭活HIV-1可以防止最初的感染,并抑制病毒在已经感染的个体中的传播。最近,我们报道了一种名为CVN-DAVEI的分子的发现,它选择性地诱导完全传染性的BALH IV-1和假型病毒的破坏性裂解。我们的愿景是,CVN-DAVEI利用Env复合体固有的亚稳性来摧毁病毒,这种亚稳性是一个致命弱点,可以根据这种亚稳性设计出一类新型的灭活艾滋病毒的“猎人-杀手”分子。虽然HIV-1的失活表型很诱人,但我们对DAVEI功能的结构机制的了解还不完全。在这项提案中,我们将确定这一机制,并使用由此产生的机制基础,转向更小的和更临床相关的HIV-1灭活剂先导化合物。我们的项目团队将体现所需的蛋白质科学、分子设计、化学合成和计算结构分析专业知识,以实现这些首要目标。提出了三个相互关联的具体目标。目的1.确定DAVEI MPER结构域在HIV-1裂解灭活中的作用机制。目的2.通过DAVEI凝集素结构域和DAVEI化学计量学来确定环境多糖结合的机制:环境尖峰相遇。目的3.通过设计新的DAVEI融合结构,明确包膜结构和构象可塑性在DAVEI裂解灭活HIV-1中的作用。总体而言,这项工作将定义双结合分子对病毒裂解功能的最低要求。反过来,这些结果将扩大我们对病毒亚稳性的理解,这是HIV-1细胞感染所必需的,可以被用于DAVEI诱导的HIV-1裂解。该项目将产生“猎人杀手”先导化合物,这将为预防传播和抗击感染开辟新的分子设计策略。最后,设计到这些抗HIV构建体中的病毒裂解活性将为设计分子来对抗其他亚稳态包膜病毒,如流感、埃博拉和登革热提供先例。
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this project is to develop a new paradigm for targeting the HIV-1 envelope in order to inactivate the virus specifically, and before
host cell encounter. The uniquely HIV-1-specific envelope spike protein, comprised of the trimeric complex of gp120 and gp41 heterodimers embedded in the virus membrane, is the only virus-specific protein exposed on the outside of the virion particle and thus is an attractive targt for neutralizing the virus. HIV-1 inactivation by targeting the Env protein could prevent initial infection, and suppress virus spread in already-infected individuals. Recently, we reported the discovery of a molecule termed CVN-DAVEI that selectively induced destructive lysis of both fully infectious BaL HIV-1 and pseudotyped virus. Our vision is that CVN-DAVEI takes advantage of the inherent metastability of the Env complex to destroy the virus, and that this metastability is an Achilles' heel against which a new class of HIV- inactivating "hunter-killer" molecules can be designed. While the HIV-1 inactivation phenotype is enticing, our understanding of the structural mechanism of DAVEI function is incomplete. In this proposal, we will determine this mechanism and use the resulting mechanistic underpinning to move towards smaller and more clinically relevant HIV-1 inactivator lead compounds. Our project team will embody the required protein science, molecular design, chemical synthesis and computational structure analysis expertise to accomplish these overarching goals. Three interconnected Specific Aims are proposed. Aim 1. Determine the mechanism of the DAVEI MPER domain in the lytic inactivation of HIV-1. Aim 2. Determine the mechanism of Env glycan engagement by the DAVEI lectin domain and the stoichiometry of DAVEI:Env spike encounter. Aim 3. Define the roles of Env structure and conformational plasticity in the lytic inactivation of HIV-1 by DAVEI via the design of novel DAVEI fusion constructs. Overall, this work will define the minimum requirements for virolytic function by dual-binding molecules. In turn, the results will expand our understanding on how the virus metastability, that is a requirement for HIV-1 cell infection, can be exploited for DAVEI-induced HIV-1 lysis. The project will yield "hunter-killer" lead compounds that will open up new molecular design strategies for preventing transmission and battling infection. Finally, the virolysis activity engineered into these anti-HIV constructs wll provide precedent to design molecules to combat other metastable enveloped viruses, such as influenza, Ebola, and dengue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Combining Molecular Simulations and Biophysical Methods to Characterize Conformational Dynamics of the HIV-1 Envelope Glycoprotein
-
批准号:10749273
-
项目类别:
-
资助金额:$82.51万
-
财政年份:2023
-
负责人:CAMERON F ABRAMS
-
依托单位:
Approaches to computing diffusion rates in proteins from transition path theory
-
批准号:8510669
-
项目类别:
-
资助金额:$15.47万
-
财政年份:2011
-
负责人:CAMERON F ABRAMS
-
依托单位:
Approaches to computing diffusion rates in proteins from transition path theory
-
批准号:8663929
-
项目类别:
-
资助金额:$11.08万
-
财政年份:2011
-
负责人:CAMERON F ABRAMS
-
依托单位:
Transition Path Theory and Markovian Milestoning for Prediction of Protein-Ligand Binding Kinetics in Molecular Simulations
-
批准号:10001532
-
项目类别:
-
资助金额:$36.66万
-
财政年份:2011
-
负责人:CAMERON F ABRAMS
-
依托单位:
HIV-1 gp120 Conformational Transitions in Activation and Antagonism
-
批准号:8140704
-
项目类别:
-
资助金额:$23.89万
-
财政年份:2011
-
负责人:CAMERON F ABRAMS
-
依托单位:
Transition Path Theory and Markovian Milestoning for Prediction of Protein-Ligand Binding Kinetics in Molecular Simulations
-
批准号:9239595
-
项目类别:
-
资助金额:$40.31万
-
财政年份:2011
-
负责人:CAMERON F ABRAMS
-
依托单位:
Approaches to computing diffusion rates in proteins from transition path theory
-
批准号:8244584
-
项目类别:
-
资助金额:$39.61万
-
财政年份:2011
-
负责人:CAMERON F ABRAMS
-
依托单位:
Approaches to computing diffusion rates in proteins from transition path theory
-
批准号:8324191
-
项目类别:
-
资助金额:$37.39万
-
财政年份:2011
-
负责人:CAMERON F ABRAMS
-
依托单位:
HIV-1 gp120 Conformational Transitions in Activation and Antagonism
-
批准号:8238278
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2011
-
负责人:CAMERON F ABRAMS
-
依托单位:
Chimeric Virucides Based on a Novel Theory of Viral Metastability
-
批准号:8312616
-
项目类别:
-
资助金额:$33.84万
-
财政年份:2009
-
负责人:CAMERON F ABRAMS
-
依托单位:
Chimeric Virucides Based on a Novel Theory of Viral Metastability
-
批准号:7920879
-
项目类别:
-
资助金额:$34.12万
-
财政年份:2009
-
负责人:CAMERON F ABRAMS
-
依托单位:
Chimeric Virucides Based on a Novel Theory of Viral Metastability
-
批准号:8132409
-
项目类别:
-
资助金额:$33.85万
-
财政年份:2009
-
负责人:CAMERON F ABRAMS
-
依托单位:
Chimeric Virucides Based on a Novel Theory of Viral Metastability
-
批准号:7737690
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2009
-
负责人:CAMERON F ABRAMS
-
依托单位:
Core A Computational Core
-
批准号:10471370
-
项目类别:
-
资助金额:$13.62万
-
财政年份:1997
-
负责人:CAMERON F ABRAMS
-
依托单位:
Core A Computational Core
-
批准号:10240538
-
项目类别:
-
资助金额:$13.66万
-
财政年份:1997
-
负责人:CAMERON F ABRAMS
-
依托单位:
Core A Computational Core
-
批准号:9763627
-
项目类别:
-
资助金额:$13.69万
-
财政年份:--
-
负责人:CAMERON F ABRAMS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: